文献速递骨显像与常规 SPECT肿瘤 PET/CT

乳腺癌骨转移的影像学检查

Imaging of Bone Metastases in Breast Cancer.
PubMed 文献 · Semin Nucl Med · 2022-02-27

乳腺癌骨转移是晚期乳腺癌常见播散部位,造成高疾病负担与医疗费用。影像学长期用于骨分期与疗效评估,近年分子与混合成像(SPECT/CT、PET、MRI扩散加权成像)显著发展,可更敏感特异地检出骨转移并更准确早期评估治疗反应,从而改善患者管理。

要点

  • 乳腺癌骨转移常见,影像学用于分期与疗效评估已数十年。
  • SPECT/CT、骨特异性与肿瘤特异性PET示踪剂及MRI扩散加权成像等分子与混合成像显著发展。
  • 这些进展可更敏感特异地检出骨转移,并更准确更早评估治疗反应。

核心结论

  • 影像学发展使骨转移检测更敏感特异、治疗反应评估更准确更早,从而改善患者管理。

研究设计与样本

  • 本文为综述,讨论乳腺癌骨转移的影像学检查方法及其进展。

主要发现

  • 骨转移是晚期乳腺癌常见播散部位,造成疾病负担与高医疗费用。
  • 历史上使用X线、CT和骨扫描进行骨分期与疗效评估。
  • 近年分子与混合成像显著发展,包括骨扫描加入SPECT/CT、骨特异性与肿瘤特异性示踪剂PET、以及MRI联合功能扩散加权成像。
  • 骨特异性示踪剂可探查骨微环境,肿瘤特异性方法可探查癌细胞特征,补充CT或MRI的形态学表现。
  • 不断积累的证据表明影像学进展可更敏感特异地检出骨转移并更准确更早评估治疗反应。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Bone metastases are a common site of spread in advanced breast cancer and responsible for morbidity and high health care costs. Imaging contributes to staging and response assessment of the skeleton and has been instrumental in guiding patient management for several decades. Historically this has been with radiographs, computed tomography and bone scans. More recently, molecular and hybrid imaging methods have undergone significant development, including the addition of single photon emission computed tomography/computed tomography to the bone scan, positron emission tomography, with bone-specific and tumor-specific tracers, and magnetic resonance imaging with complementary functional diffusion-weighted imaging. These have allowed different aspects of the abnormal biology associated with bone metastases to be explored. There is ability to interrogate the bone microenvironment with bone-specific tracers and cancer cell characteristics with tumor-specific methods that complement morphological appearances on computed tomography or magnetic resonance imaging. Alongside the advent of novel, more effective and nuanced therapies for bone metastases in breast cancer, there is accumulating evidence that the developments in imaging allow more sensitive and specific detection of bone metastases as well as more accurate and earlier assessment of treatment response leading to improvements in patient management.

来源:Semin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Cook GJR. Imaging of Bone Metastases in Breast Cancer. Semin Nucl Med. 2022. PMID: 35236615. doi:10.1053/j.semnuclmed.2022.01.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。